Literature DB >> 15110052

Community-based screening for cardiovascular disease and diabetes using HbA1c.

Taneisha Grant1, Yukmila Soriano, Paul R Marantz, Ingrid Nelson, Eric Williams, Diana Ramirez, Jean Burg, Charles Nordin.   

Abstract

BACKGROUND: Persons from inner-city immigrant and mixed-ethnic communities are known to be at high risk for cardiovascular disease and diabetes. Such communities may also be underserved for preventive medical care. The authors hypothesized that hemoglobin A1c (HbA1c) could be used as a screening test for a community-based program to detect new cases of diabetes and persons at risk for diabetes and cardiovascular disease.
METHODS: Screenings took place in churches, group homes, shelters, community centers, and street corners of the Bronx. Screening data included history of diabetes, age, ethnicity, body mass index, blood pressure, lipid panel, random glucose, and HbA1c. Data were analyzed for number of cases of new diabetes (HbA1c > or =7%), for patients at risk for diabetes (HbA1c 6%-6.99%), and for associations between HbA1c and other variables. The effect of location of screening and self-reported ethnicity on outcome variables was also analyzed.
RESULTS: Seven hundred four persons were screened in 25 different sessions. HbA1c and lipid profile were obtained on 539 persons, which formed the cohort for analysis. Mean HbA1c for the cohort was 6.00%. Thirty-two percent of the cohort had HbA1c of more than 6%, and 11.4% had HbA1c of more than 7%. Excluding known diabetics (13% of cohort), 24% had HbA1c of more than 6%, and 3.4% had HbA1c of more than 7%. HbA1c was significantly correlated with total cholesterol, triglycerides, low-density lipoprotein, systolic blood pressure, body mass index, and age; in all cases, correlation coefficients were higher with HbA1c than with random glucose. In addition, significantly higher cardiovascular disease risk factors were found in persons with HbA1c of more than 6%; 6% may be a threshold value for the metabolic syndrome. Mean HbA1c was higher in persons from the South Bronx (which has a higher poverty rate) than the North Bronx (6.08% v 5.74%, p=0.013). There were no statistically significant differences between self-reported ethnic groupings.
CONCLUSIONS: There was a high prevalence of undiagnosed diabetes, and of patients at risk for diabetes, in this community setting. Community-based screening can be used as a method for identifying high percentages of patients at risk for diabetes or with undiagnosed diabetes in an inner city, immigrant, mixed-ethnic population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110052     DOI: 10.1016/j.amepre.2003.12.015

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  9 in total

1.  The use of dried blood spot sampling in the national social life, health, and aging project.

Authors:  Sharon R Williams; Thomas W McDade
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-02-25       Impact factor: 4.077

2.  Observations and recommendations for community-based diabetes screenings.

Authors:  Brian West; Punam Parikh; Guedy Arniella; Carol R Horowitz
Journal:  Diabetes Educ       Date:  2010-11-01       Impact factor: 2.140

3.  Metabolic syndrome and cognitive decline among the oldest old in Okinawa: in search of a mechanism. The KOCOA Project.

Authors:  Yuriko Katsumata; Hidemi Todoriki; Yasushi Higashiuesato; Shotoku Yasura; D Craig Willcox; Yusuke Ohya; Bradley J Willcox; Hiroko H Dodge
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-10-20       Impact factor: 6.053

4.  Utilizing the Probation Office as an Opportunity to Screen for Cardiometabolic Outcomes: A Feasibility Study.

Authors:  Kimberly R Dong; Curt G Beckwith; Anna Grossman; Daniel E Weiner; Alice H Lichtenstein
Journal:  J Correct Health Care       Date:  2022-06-10

5.  Integrating Rapid Diabetes Screening Into a Latinx Focused Community-Based Low-Barrier COVID-19 Testing Program.

Authors:  Andrew D Kerkhoff; Susana Rojas; Douglas Black; Salustiano Ribeiro; Susy Rojas; Rebecca Valencia; Jonathan Lemus; Joselin Payan; John Schrom; Diane Jones; Simone Manganelli; Shalom Bandi; Gabriel Chamie; Valerie Tulier-Laiwa; Maya Petersen; Diane Havlir; Carina Marquez
Journal:  JAMA Netw Open       Date:  2022-05-02

6.  The effect of integrated health care in patients with hypertension and diabetes: a systematic review and meta-analysis.

Authors:  Yan Zhao; Yue Ma; Chongbo Zhao; Jiahong Lu; Hong Jiang; Yanpei Cao; Yafang Xu
Journal:  BMC Health Serv Res       Date:  2022-05-05       Impact factor: 2.908

Review 7.  Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience.

Authors:  Deborah Taira Juarez; Kendra M Demaris; Roy Goo; Christina Louise Mnatzaganian; Helen Wong Smith
Journal:  Diabetes Metab Syndr Obes       Date:  2014-10-20       Impact factor: 3.168

8.  Diabetes Prevalence Survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan.

Authors:  Azizul Hasan Aamir; Zia Ul-Haq; Saeed A Mahar; Faisal Masood Qureshi; Ibrar Ahmad; Ali Jawa; Aisha Sheikh; Abbas Raza; Sheraz Fazid; Zahid Jadoon; Osama Ishtiaq; Nauman Safdar; Hussain Afridi; Adrian H Heald
Journal:  BMJ Open       Date:  2019-02-21       Impact factor: 2.692

9.  Performance of Fasting Plasma Glucose and Postprandial Urine Glucose in Screening for Diabetes in Chinese High-risk Population.

Authors:  Bing-Quan Yang; Yang Lu; Jia-Jia He; Tong-Zhi Wu; Zuo-Ling Xie; Cheng-Hao Lei; Yi Zhou; Jing Han; Mei-Qi Bian; Hong You; De-Xian Mei; Zi-Lin Sun
Journal:  Chin Med J (Engl)       Date:  2015-12-20       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.